Epidemiology of nosocomial fungal infections

Clinical Microbiology Reviews

Volumn 9, Issue 4, 1996, Pages 499-511

  Fridkin, Scott K ^a   Jarvis, William R ^b,c  

^a RUSH MEDICAL COLLEGE   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ASPERGILLOSIS; CANDIDIASIS; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; FUNGUS GROWTH; FUSARIUM; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFECTION CONTROL; MALASSEZIA; MUCORMYCOSIS; MYCOSIS; PATHOGENESIS; REVIEW; RISK FACTOR; TRICHOSPORON; ZYGOMYCETES;

CANDIDA; CANDIDA GLABRATA; FUNGI; FUSARIUM; MALASSEZIA; TORULOPSIS; ZYGOMYCETES;

EID: 0029959130     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.9.4.499-511.1996     Document Type: Review

References (116)

1. Aisner, J., S. C. Schimpff, J. E. Bennett, V. M. Younge, and P. H. Wiernik. 1976. Aspergillus infections in cancer patients. Association with fireproofing in new hospitals. JAMA 235:411-412.
2. American Institute of Architects Committee on Architecture for Health, U.S. Department of Health and Human Services. 1992. Guidelines for construction and equipment of hospital and medical facilities. The American Institute of Architects Press, Washington, D.C.
3. Anaissie, E., and G. P. Bodey. 1989. Nosocomial fungal infections: old problems and new challenges. Infect. Dis. Clin. North Am. 3:867-882.
4. Anaissie, E. J., G. P. Bodey, and M. G. Rinaldi. 1989. Emerging fungal pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 8:323-330.
5. Arnow, P. M., R. I. Anderson, P. D. Mainous, and E. J. Smith. 1978. Pulmonary aspergillosis during hospital renovation. Am. Rev. Respir. Dis. 118:49-53.
6. Arnow, P. M., M. Sadigh, C. Costas, D. Weil, and R. Chudy. 1991. Endemic and epidemic aspergillosis associated with in-hospital replication of aspergillus organisms. J. Infect. Dis. 164:998-1002.
7. Banerjee, S. N., T. G. Emori, D. H. Culver, R. P. Gaynes, W. R. Jarvis, T. Horan, J. R. Edwards, J. Tolson, T. Henderson, and W. J. Martone. 1991. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am. J. Med. 91(Suppl. 3B):86S-89S.
8. Barg, N. L. 1993. An introduction to molecular hospital epidemiology. Infect. Control Hosp. Epidemiol. 14:395-396.
9. Beck-Sague, C. M., W. R. Jarvis, and the National Nosocomial Infections Surveillance System. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167: 1247-1251.
10. Bennett, S. N., M. M. McNeil, L. A. Bland, M. J. Arduino, M. E. Villarino, D. M. Perrotta, D. R. Burwen, S. F. Welbel, D. A. Pegues, L. Stroud, and W. R. Jarvis. 1995. Postoperative infections traced to extrinsic contamination of an intravenous anesthetic. N. Engl. J. Med. 333:147-154.
11. Bodey, G. P. 1988. The emergence of fungi as major hospital pathogens. J. Hosp. Infect. 11(Suppl. A):411-426.
12. Bor-von Zepelin, M., H. Eiffert, M. Kann, and R. Ruchel. 1993. Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Gottingen, Germany. Mycoses 36(7-8):247-253.
13. Branchini, M. L., M. A. Pfaller, J. Rhine-Chalberg, T. Frampong, and H. D. Isenberg. 1994. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J. Clin. Microbiol. 32:452-456.
14. Bross, J., G. H. Talbot, G. Maislin, S. Hurwitz, and B. L. Strom. 1989. Risk factors for nosocomial candidemia: a case-control study. Am. J. Med. 87: 614-620.
15. Brown, N. M., E. L. Blundell, S. R. Chown, D. W. Warnock, J. A. Hill, and R. R. Slade. 1992. Acremonium infection in a neutropenic patient. J. Infect. 25:73-76.
16. Chang, H., H. Miller, N. Watkins, M. Aruino, S. Aguero, D. Ashford, R. Pinto-Powell, C. F. BonReyn, W. Edward, G. Midgelv, R. Pruitt, M. McNeil, and W. R. Jarvis. 1995. Malassezia pachydermatis fungemia in neonatal intensive care unit patients, abstr. J-51, p. 268. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
17. Codish, S. D., I. D. Sheridan, and A. P. Monaco. 1978. Mycotic wound infections. A new challenge for the surgeon. Arch. Surg. 114:831-835.
18. Colombo, A. L., F. Barchiesi, D. A. McGough, and M. G. Rinaldi. 1995. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J. Clin. Microbiol. 33:535-540.
19. Danker, W. M., S. A. Spector, J. Fierer, and C. E. Davis. 1987. Malassezia fungemia in neonates and adults: complication of hyperalimentation. Rev. Infect. Dis. 9:743-753.
20. Danna, P. L., C. Urban, E. Bellin, and J. J. Rahal. 1991. Role of candida in pathogenesis of antibiotic-associated diarrhea is elderly inpatients. Lancet 337:511-514.
21. Dube, M. P., P. N. Heseltine, M. G. Rinaldi, S. Evans, and B. Zawacki. 1994. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin. Infect. Dis. 18:77-82.
22. Edwards, J. E., Jr. 1991. Invasive candida infections - evolution of a fungal pathogen. N. Engl. J. Med. 324:1060-1062.
23. Eickhoff, T. C. 1994. Airborne nosocomial infection: a contemporary perspective. Infect. Control Hȯsp. Epidemiol. 15:663-673.
24. El-Mohandes, A. E., L. Johnson-Robins, J. F. Keiser, S. J. Simmens, and M. V. Aure. 1994. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease. Pediatr. Infect. Dis. J. 13:520-524.
25. Emori T. G., and R. P. Gaynes. 1993. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6:428-442.
26. Fincher-Ruth, M. E., J. F. Fisher, R. D. Lovell, C. L. Newman, A. Espinel-Ingroff, and H. J. Shadomy. 1991. Infection due to the fungus Acremonium (Cephalosporioum). Medicine 70:398-409.
27. Finkelstein, R., G. Reinhertz, N. Hashman, and D. Merzbach. 1993. Outbreak of Candida tropicalis fungemia in a neonatal intensive care unit Infect. Control Hosp. Epidemiol. 14:587-590.
28. Fisher, D. J., C. Christy, P. Spafford, W. M. Maniscalco, D.J. Hardy, and P. S. Graman. 1993. Neonatal Trichosporon beigelii infection: report of a cluster of cases in a neonatal intensive care unit. Pediatr. Infect. Dis. J. 12:149-155.
29. Fisher-Hoch, S. P., and L. Hutwagner. 1995. Opportunistic candidiasis: an epidemic of the 1980s. Clin. Infect. Dis. 21:897-904.
30. Fraser, V. J., M. Jones, J. Dunkel, S. Storfer, G. Medoff, and W. C. Dunagan. 1992. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin. Infect. Dis. 15:414-421.
31. Fridkin, S. K., A. Padhye, F. Kremer, L. Bland, and W. Jarvis. 1996. Acremonium kiliense endophthalmitis that occurred after cataract extraction in an ambulatory surgical center and was traced to an environmental reservoir. Clin. Infect. Dis. 22:222-227.
32. Galgiani, J. N., J. Reiser, C. Brass, A. Espinel-Ingroff, M. A. Gordon, and T. M. Kerkering. 1987. Comparison of relative susceptibilities of Candida spp. to three antifungal agents as determined by unstandardized methods. Antimicrob. Agents Chemother. 31:1343-1347.
33. Garcia, M., J. Burt, R. Reilly, R. Kaul, I. Campbell, R. Summerbell, and J. M. Conly. 1994. Contamination of multi-dose vials of technetium-99M-sestamibi with Acremonium kiliens, abstr. 208, p. 92. In Abstracts of the Association for Practitioners for Infection Control Annual Conference 1994. Association for Practitioners for Infection Control, Washington D.C.
34. Gerson, S. L., P. Parker, M. R. Jacobs, R. Creger, and H. M. Lazarus. 1994. Aspergillosis due to carpet contamination. Infect. Control Hosp. Epidemiol. 15:221-223.
35. Girardin, J., J. Sarfati, F. Traore, J. D. Camet, F. Derouin, and J. P. Latge. 1994. Molecular epidemiology of nosocomial invasive aspergillosis. J. Clin. Microbiol. 32:684-690.
36. Goodman, J. L., D. J. Winston, R. A. Greenfield, P. H. Chandrasekar, B. Fox, H. Kaizer, R. K. Shadduck, T. C. Shea, P. Stiff, and D. J. Friedman. 1992. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. 3. Med. 326:845-851.
37. Gupta, T. P., and M. N. Ehrinpreis. 1990. Candida-associated diarrhea in hospitalized patients. Gastroenterology 98:780-785.
38. Hajjeh, R. A., and H. M. Blumberg. 1995. Bloodstream infection due to Trichosporon beigelii in a burn patient: case report and review of therapy. Clin. Infect. Dis. 20:913-916.
39. Harvey, R. L., and J. P. Myers. 1987. Nosocomial fungemia in a large community teaching hospital. Arch. Intern. Med. 147:2117-2120.
40. Iwata, K. 1992. Drug resistance in human pathogenic fungi. Eur. J. Epidemiol. 8:407-421.
41. Iwen, P. C., J. C. Davis, E. C. Reed, B. A. Winfield, and S. H. Hinrichs. 1994. Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis. Infect. Control Hosp. Epidemiol. 15:303-306.
42. Jeffrey, W. R., J. E. Hernandez, A. L. Zarraga, G. E. Oley, and L. W. Kitchen. 1993. Disseminated infection due to Acremonium species in a patient with Addison's Disease. Clin. Infect. Dis. 16:179.
43. Kammer, R. B., and J. P. Utz. 1974. Aspergillus species endocarditis: the new face of a not so rare disease. Am. J. Med. 56:506-521.
44. Karabinis, A., C. Hill, B. Leclerq, C. Tancrede, D. Baume, and A. Andremont. 1988. Risk factors for candidemia in cancer patients: a case-control study. J. Clin. Microbiol. 26:429-432.
45. Keys, R. F., A. M. Halderson, and K. H. Rhodes. 1978. Nosocomial outbreak of Rhizopus infections associated with Elastoplast wound dressings - Minnesota. Morbid. Mortal. Weekly Rep. 27:33-34.
46. Komshian, S. V., A. Uwaydah, J. D. Sobel, and L. R. Crane. 1989. Fungemia caused by Candida species and Torudopsis glabrata in the hospitalized patient : frequency, characteristics, and evaluation of factors influencing outcome. Rev. Infect. Dis. 11:379-390.
47. Kontou-Kastellanon, C., J. Leonardopoulos, L. Boniatsi, S. Kastellanos, and P. Toutouzas. 1990. A case of Candida parapsilosis endocarditis. Mycoses 33:427-429.
48. Lecciones, J. A., J. W. Lee, E. E. Navarro, F. G. Witebsky, D. Marshall, S. M. Steinberg, P. A. Pizza, and T. J. Walsh. 1992. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin. Infect. Dis. 14:875-883.
49. Liescke, G. J., and A. W. Burgess. 1992. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N. Eng. J. Med. 327:28-35.
50. Marcon, M. J., and D. A. Powell. 1992. Human infections due to Malassezia species. Clin. Microbiol. Rev. 5:101-119.
51. McCray, E., N. Rampell, S. L. Solomon, W. W. Bond, and W. J. Martone. 1986. Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation. J. Clin. Microbiol. 24:625-628.
52. McNeil, M. M. 1996. Candida. In G. Mayhall (ed.), Hospital epidemiology and infection control. The Williams & Wilkins Co., Baltimore.
53. Meunier-Carpentier, F., T. E. Kiehn, and D. Armstrong. 1981. Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am. J. Med. 71:363-370.
54. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
55. Nelson, S. C., Y. C. Yau, S. E. Richardson, and A. G. Matlow. 1995. Improved detection of Malassezia species in lipid-supplemented Peds Plus blood culture bottles. J. Clin. Microbiol. 33:1005-1007.
56. Otaki, M., and N. Kitamura. 1973. Candida prosthetic valve endocarditis. An autopsy review. Int. Surg. 78:252-253.
57. Pannuti, C. S., R. D. Gingrich, M. A. Pfaller, and R. P. Wenzel. 1991. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. J. Clin. Oncol. 9:77-84.
58. Paparello, S. F., R. L. Parry, D. C. MacGillivray, N. Brock, and D. L. Mayers. 1992. Hospital-acquired wound mucormycosis. din. Infect. Dis. 14:350-352.
59. Patterson, T. F., V. T. Andriole, M. J. Zervos, D. Therasse, and C. A. Kauffman. 1990. The epidemiology of pseudoallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses 33:297-302.
60. Paul, J., S. H. White, K. M. Nicholls, and D. W. Crook. 1992. Prosthetic joint infection due to Candida parapsilosis in the UK: case report and literature review. Eur. J. Clin. Microbiol. Infect. Dis. 11:847-849.
61. Peacock, J. E., A. J. Morris, D. C. Tanner, M. L. Nguyen, V. L. Snydraan, and U. Yu. 1994. The changing face of candidemia: results of a large scale prospective multicenter study, abstr. J107, p. 106. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
62. Perfect, J. R., N. Ketabchi, G. M. Cox, C. W. Ingram, and C. L. Beiser. 1993. Karyotyping of Cryptococcus neoformans as an epidemiological tool. J. Clin. Microbiol. 31:3305-3309.
63. Petit, T. H., R. J. Olson, R. Y. Foos, and W. J. Martin. 1980. Fungal endophthalmitis following intraocular lens implantation: a surgical epidemic. Arch. Ophthalmol. 98:1025-1039.
64. Pfaller, M., and R. Wenzel. 1992. Impact of changing epidemiology of fungal infections in the 1990s. Eur. J. Clin. Microbiol. Infect. Dis. 11:287-291.
65. Pfaller, M. A. 1992. Epidemiological typing methods for mycoses. Clin. Infect. Dis. 14(Suppl.):S4-S10.
66. Pfeller, M. A. 1992. The use of molecular techiques for epidemiologic typing of Candida species. Curr. Top. Med. Mycol. 4:43-63.
67. Pfeller, M. A. 1994. Epidemiology and control of fungal infections. Clin. Infect. Dis. 19(Suppl. 1):S8-S13.
68. Pfeller, M. A., S. Messer, and R. Hollis. 1994. Genotypic variation, antifungal susceptibility, and slime production among isolates of Candida parapsilosis, abstr. J104, p. 105. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
69. Pfeller, M. A., S. Messer, and R. Hollis. 1994. Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae from 12 different medical centers, abstr. J103, p: 105. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
70. Pfeller, M. A., J. H. Rex, and A. L. Barry. 1994. Strain variation and antifungal susceptibility among 280 isolates of Candida from nonneutropenic patients with candidemia, abstr. J105, p. 105. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
71. Rangel-Frausto, M. S., M. A. Martin, H. Saiman, H. Blumberg, J. E. Paterson, M. A. Pfaller, R. P. Wenzel, and the NEMIS Study Group. 1994. High prevalence of Candida spp. on hands of health care workers in surgical and neonatal intensive care units, abstr. J106, p. 105. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
72. Reagan, D. R., M. A. Pfeller, R. J. Hollis, and R. P. Wenzel 1990. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J. Clin. Microbiol. 28:2733-2738.
73. Reingold, A. L., X. D. Lu, B. D. Plikaytis, and L. Ajello. 1986. Systemic Mycoses in the United States, 1980-1982. J. Med. Vet. Mycol. 24:433-436.
74. Rex, J. H., M. A. Pfaller, M. G. Rinaldi, A. Potak, and J. N. Galgiani. 1993. Antifungal susceptibility testing. Clin. Microbiol. Rev. 6:367-381.
75. Rhame, F. S. 1991. Prevention of nosocomial aspergillosis. J. Hosp. Infect. 18(Suppl. A):466-472.
76. Rhame, F. S. 1992. The inanimate environment, p. 301-307. In J. V. Bennett and P. S. Brachman (ed.), Hospital infections, 3rd ed. Little, Brown & Co., Boston.
77. Richet, H. M., A. Andremont, C. Tancrede, J. L. Pico, and W. R. Jarvis. 1991. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev. Infect. Dis. 13:211-215.
78. Richet, H. M., M. M. McNeil, B. J. Davis, E. Duncan, J. Strickler, D. Nunley, W. R. Jarvis, and O. C. Tablan. 1992. Aspergillus fumigatus sternal wound infections in patients undergoing open heart surgery. Am. J. Epidemiol. 135:48-58.
79. Richet, H. M., M. M. McNeil, M. Edward, and W. R. Jarvis. 1989. Cluster of Malassezia furfur pulmonary infections in infants in a neonatal intensive-care unit J. Clin. Microbiol. 27:1197-1200.
80. Rippon, J. W. 1982. Medical mycology: the pathogenic fungi and the pathogenic actinomycetes, 2nd ed. The W. B. Saunders Co., Philadelphia.
81. Romano, F., G. Ribera, and M. Giuliano. 1994. A study of a hospital cluster of systemic candidiasis using DNA typing methods. Epidemiol. Infect 112: 393-398.
82. Rowsey, J. J., T. E. Acers, D. L. Smith, J. A. Mehr, D. L. Newsom, and J. Rodriguez. 1979. Fusarium oxysporum endophthalmitis. Arch. Ophthalmol. 97:103-105.
83. Sanchez, V., J. A. Vazquez, D. Barth-Jones, L. Dembry, and J. D. Sobel. 1993. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am. J. Med. 94:577-582.
84. Sanchez, V., J. A. Vazquez, D. Barth-Jones, L. Dembry, J. D. Sobel, and M. J. Zervos. 1992. Epidemiology of nosocomial acquisition of Candida lusitaniae. J. Clin. Microbiol. 30:3005-3008.
85. Schaberg, D. R., D. H. Culver, and R. P. Gaynes. 1991. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91(Suppl. 3B):72S-75S.
86. Schonian, G., O. Meusel, H. J. Tietz, W. Meyer, Y. Graser, I. Tausch, W. Presber, and T. G. Mitchell. 1993. Identification of clinical strains of Candida albicans by DNA fingerprinting with the polymerase chain reaction. Mycoses 36:171-179.
87. Schwartz, R. S., F. R. Mackintosh, S. L. Schirier, and P. L. Greenberg. 1984. Multivariate analysis of factors associated with invasive fungal disease during remission-induction therapy for acute myelogenous leukemia. Cancer 53:411-419.
88. Senenba, M., K. Watanabe, K. Yoshida, S. Ochi, K. Matsumoto, K. Yano, and H. Itakura. 1992. Endocarditis caused by Candida parapsilosis. Southeast Asian J. Trop. Med. Public Health 23:138-141.
89. Sherertz, R. J., A. Belani, B. S. Kramer, G. J. Elfenbein, R. S. Weiner, M. L. Sullivan, R. G. Thomas, and G. P. Samsa. 1987. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am. J. Med. 83:1987.
90. Solomon, S. L., H. Alexander, J. W. Eley, R. L. Anderson, H. C. Goodpasture, S. Smart, R. M. Furman, and W. J. Martone. 1986. Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices. Pediatr. Infect. Dis. J. 5:680-685.
91. Solomon, S. L., R. F. Khabbaz, R. H. Parker, R. L. Anderson, M. A. Geraghty, R. M. Furman, and W. J. Martone. 1984. An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J. Infect. Dis. 149:98-102.
92. Stuart, S. M., and A. T. Lane. 1992. Candida and Malassezia as nursery pathogens. Semin. Dermatol. 11:19-23.
93. Summerbell, R. C. 1993. The benomyl test as a fundamental diagnostic method for medical mycology. J. Clin. Microbiol. 31:572-577.
94. Symoens, F., M. A. Viviani, and N. Nolard. 1993. Typing by immunoblot of Aspergillus fumigatus from nosocomial infections. Mycoses 36:229-237.
95. Tablan, O. C., L. J. Anderson, N. H. Arden, R. F. Breiman, J. C. Butler, M. M. McNeil, and the Hospital Infections Practices Advisory Committee. 1994. Guideline for prevention of nosocomial pneumonia, Centers for Disease Control and Prevention. Respir. Care 39:1191-1236.
96. Van Belkum, A., T. Boekhout, and R. Bosboom. 1994. Monitoring spread of Malassezia infections in a neonatal intensive care unit by PCR-mediated genetic typing. J. Clin. Microbiol. 32:2528-2532.
97. Vazquez, J. A., V. Sanchez, C. Dmuchowski, L. M. Dembry, J. D. Sebel, and M. J. Zervos. 1993. Nosocomial acquisition of Canadida albicans: an epidemiologic study. J. Infect. Dis. 168:195-201.
98. Walmsley, S., S. Devi, S. King, R. Schneider, S. Richardson, and L. Ford-Jones. 1993. Invasive aspergillus infections in a pediatric hospital: a tenyear review. Pediatr. Infect. Dis. J. 12:673-682.
99. Walsh, T. J., and D., M. Dixon. 1989. Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment. Eur. J. Epidemiol. 5:131-142.
100. Walsh, T. J., G. P. Melcher, M. G. Rinaldi, J. Lecciones, D. A. McGough, P. Kelly, J. Lee, D. Callender, M. Rubin, and P. A. Pizzo. 1990. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J. Clin. Microbiol. 28:1616-1622.
101. Walsh, T. J., K. R. Newman, M. Moody, R. C. Wharton, and J. C Wade. 1986. Trichosporonosis in patients with neoplastic disease. Medicine 65: 268-279.
102. Weems, J. J., A. Andremont, B. J. Davis, C. H. Tancrede, M. Guiguet, A. A. Padhye, F. Squinazi, and W. J. Martone. 1987. Pseudoepidemic of aspergillosis after development of pulmonary infiltrates in a group of bone marrow transplant patients. J. Clin. Microbiol. 25:1459-1462.
103. Weems, J. J. J. 1992. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin. Infect. Dis. 14:756-766.
104. Weems, J. J. J., M. E. Chamberland, J. Ward, M. Willy, A. A. Padnye, and S. L. Solomon. 1987. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J. Clin. Microbiol. 25:1029-1032.
105. Welbel, S., M. McNeil, A. Pramanik, and T. Lott. 1992. An outbreak of fungemias due to Candida parapsilosis from a multi-dose bottle of liquid glycerin in a neonatal intensive care unit, abstr. F-18. In Abstracts of the 92nd Annual Meeting of the American Society of Microbiology 1992. American Society for Microbiology, Washington, D.C.
106. Welbel, S. F., M. M. McNeil, A. Pramanik, R. Silberman, A. D. Oberle, G. Midgley, S. Crow, and W. R. Jarvis. 1994. Nosocomial Malassezia pachydermatis bloodstream infections in a neonatal intensive care unit Pediatr. Infect. Dis. J. 13:104-108.
107. Wenzel, R. P., and M. A. Pfaller. 1991. Candida species: emerging hospital bloodstream pathogens. Infect. Control Hosp. Epidemiol. 12:523-524.
108. Wey, S. B., M. Mori, M. Pfaller, R. Woolson, and R. P. Wenzel. 1988. Hospital-acquired candidemia: the attributable mortality, and excess length of stay. Arch. Intern. Med. 148:2642-2645.
109. Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1989. Risk factors for hospital-acquired candidemia. Arch. Intern. Med. 149: 2349-2353.
110. Widmer, A. F., A. Gratwohl, B. Orth, M. Uhr, M. Rinaldi, and R. Frei. 1994. Contaminated skin lotion: the source for an outbreak of Paecilomyces litacinus infections at a BMT unit, abstr. 1245, p. 241. in Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
111. Wiley, J. M., N. Smith, B. G. Leventhal, R. Silberman, A. D. Oberle, G. Midgley, S. Crow, and W. R. Jarvis. 1990. Invasive fungal disease in pediatric-acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. J. Clin. Oncol. 8:280-286.
112. Wingarf, J. R., W. G. Merz, M. R. Rinaldi, T. R. Johnson, J. E. Karp, and R. Saral. 1991. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 325:1274-1277.
113. Winston, D. J., P. H. Chandrasekar, H. M. Lazarus, J. L. Goodman, J. L. Silber, H. Horowitz, R. K. Shadduck, C. S. Rosenfeld, W. G. Ho, and M. Z. Islam. 1993. Fluconazole prophylaxis of fungal infections in patients with acute leukemia: results of a randomized placebo-controlled, double-blind, multicenter trial. Ann. Intern. Med. 118:495-503.
114. Young, J. B., I. H. Ahmed-Jushuf, A. M. Brwonjohn, F. M. Parsons, S. J. Foukes, and E. G. Evans. 1984. Opportunistic peritonitis in continuous ambulatory peritoneal dialysis. Clin. Nephrol. 22:268-269.
115. Young, R. C., J. E. Bennett, C. L. Vogel, P. P. Carbone, and V. T. DeVita. 1970. Aspergillosis: the spectrum of the disease in 98 patients. Medicine 49:147-173.
116. Yu, V. L., R. R. Muer, and A. Poorsattar. 1986. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results of a three-year prospective study. Am. J. Med. 81: 249-254.